Orchid Pharma up 7% after good Q2 show; PAT up 26%, revenue rises 12%

Quick Summary:

The positive trajectory is proof of our commitment to driving sustainable, profitable growth," said  Manish Dhanuka, managing director, Orchid Pharma.

Around 12:29 PM, Orchid Pharma shares were up 5.71 per cent at Rs 1,520 per share on BSE.

Orchid Pharma's manufacturing facilities are compliant with international quality standards, and the company has received Good Manufacturing Practice (GMP) certifications from regulatory agencies like the FDA.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Markets Stock market today Orchid pharma share price Orchid pharma shares Orchid pharma share price bse Q2 results

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-12 @ 12:55:52 (1 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 446 words

Reading Time: 3 minutes read

Sentences: 19 lines

Sentence Length: 24 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23547179

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 341 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 5 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions